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CULTURAL PRACTICES AND THE USE OF ICTEROGENIC AGENTS IN GLUCOSE 6 
PHOSPHATE DEHYDROGENASE DEFICIENT NEONATES: ANY EFFECT?
ABSTRACT
Background: Cultural practices involving the use of certain agents known to cause haemolysis in Glucose-6-phosphate 
dehydrogenase (G6PD) deficient individuals are common during perinatal and neonatal periods. This study was targeted 
at identifying some of these agents and their role in the development of hyperbilirubinaemia in G6PD deficient neonates 
in our environment with a view at raising public awareness for an acceptable neonatal outcome. 
Materials and methods: One hundred and fifty neonates admitted into the Special Care Baby Units (SCBUs) of the Jos 
University Teaching Hospital, Bingham University Teaching Hospital, and the Plateau State Specialist Hospital with neonatal 
jaundice were enrolled for this study. Information on age, sex, history of drugs, chemicals and herbs used during or after 
pregnancy were obtained using a questionnaire. Five millilitres of the blood sample was collected into anticoagulated and 
plain sample bottles for Full Blood Count (FBC), Reticulocyte Count, Serum Bilirubin (SB) and G6PD assay.
Results: Mean age at presentation was 3.28 ± 3.11 days. Mean haemoglobin concentration of the neonates was 15.90 ± 2.23 
9g/dL while mean reticulocyte count, total leukocyte and platelet count were 2.42 ± 0.71%, 7.10 ± 2.76 (x 10 /L) and 228.45 ± 
85.57 respectively. Sixty-one (40.7 %) of the studied neonates were G6PD deficient with mean G6PD activity of 3.79 ± 1.37 
IU/gHb. Mean total serum bilirubin was 205.01 ± 96.57µmol/L. Icterogenic agent use was identified in 70 (46.7%) of the 
study subjects with naphthalene balls used in 19 (12.7%) study subjects.
Conclusion: Icterogenic agents are being used for neonatal care in our environment despite the consequences of 
hyperbilirubinaemia in those with G6PD deficiency.
Keywords: Glucose-6-phosphate dehydrogenase deficiency, Hyperbilirubinaemia, Icterogenic agents, Neonates
NigerJmed 2020: 120-124
© 2020. Nigerian Journal of Medicine
eonatal jaundice is a term used to describe the 
yellowish discolouration of the skin, sclera, and 
mucous membranes due to the deposition of bile N
1pigments.  It develops when the rate of bilirubin 
production exceeds the rate of its elimination primarily by 
1conjugation.  It is a common clinical presentation of 
varying aetiology during the neonatal period affecting 
about 60-70% of otherwise healthy full-term neonates and 
280% of preterm neonates. Clinical jaundice is noticed 
when total serum bilirubin (TSB) exceed 85.5ìmol/L 
(5mg/dL) but not all jaundiced neonates become 
2  endangered by hyperbilirubinaemia . Bilirubin 
encephalopathy or permanent, irreversible brain damage 
is known to occur when free bilirubin crosses the blood-
brain barrier of a full-term or preterm neonates and is 
deposited in the basal ganglia and other areas of the brain. 
Neonatal jaundice has been reported to be a significant 
cause of morbidity and mortality in paediatric age group 
and an important contributing cause of cerebral palsy in 
3- 7the country.
Several factors are associated with neonatal jaundice 
among which is prematurity, sepsis, ABO and Rh 
incompatibility as well as Glucose-6-phosphate 
dehydrogenase (G6PD) deficiency an X-linked recessive 
disorder and the commonest inherited red blood cell 
enzymopathy Worldwide. G6PD deficiency has the 
highest prevalence in the tropics, subtropics and in the 
8Mediterranean countries.  In the United States of America, 
2.5% of males and 1.6% of females are deficient, with most 
8having only moderate deficiency.  The prevalence rate of 
G6PD deficiency in West Africa varies depending on the 
8-9location.  In Nigeria, the prevalence of G6PD deficiency 
ranges from 4-26% in the general population and up to 40- 
9-1143% among G6PD deficient jaundiced neonates.
Reports from many countries of the world including 
Nigeria have indicated G6PD deficiency to be a major risk 
factor for neonatal jaundice, which may occur after 
exposure to oxidant agents like infection, drugs or fava 
beans ingestion, and consequently haemolysis with excess 
12- 15bilirubin production.
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This study is aimed at identifying icterogenic agents 
commonly use in our environment with a view of raising 
awareness at avoiding them within the perinatal as well as 
the neonatal period for better neonatal outcome.
Materials and Methods
Study design and setting
A cross-sectional study involving neonates with jaundice 
admitted into the Special Care Baby Units of the Jos 
University Teaching Hospital, Bingham University 
Teaching Hospital, and Plateau State Specialist Hospital 
between March 2013 to February 2014. They were recruited 
using the non-probability convenience sampling 
technique. A standardized questionnaire was 
administered to get information on age, weight, and length 
of the neonate at birth estimated gestational age, at 
booking, and history of drugs/chemicals used in 
pregnancy or after, as well as other risk factors for 
developing neonatal jaundice.
Laboratory Procedures
Three millilitres of venous blood was taken into an EDTA 
sample bottle for full blood count (FBC) auto analysis using 
the 3-part Sysmex haematology auto-analyser (KX-21N 
2007 model). Reticulocyte count was manually performed 
using freshly prepared methylene blue as described by 
16Dacie and Lewis.  G6PD enzyme activity was determined 
using reagents manufactured by the Pointe Reagent 
Company (USA) with G6PD deficiency defined by enzyme 
activity < 6.0 IU/gHb. Two millilitres of the blood sample 
was also collected into a plain bottle for bilirubin assay by 
the Jendrassik and Grof method using the Roche/Hitachi 
902 SN 1694-019-1996 auto analyzer. 
Statistical Analysis
Epi Info Version 6 software was used for the data analysis. 
The results were reported in tables, proportions, and 
percentages while mean, median, mode and standard 
deviation (SD) were used to describe continuous variables. 
Students' t-test showed the significance between the means 
of two groups and p-value ≤ 0.05 was considered 
statistically significant. Spearman's rank correlation 
coefficient (r ) was used to determine the strength of the s
relationship between the icterogenic agents and 
development of hyperbilirubinaemia.
Ethical Consideration
Ethical approval was obtained from the Health Research 
Ethics Committees of Jos University Teaching Hospital, 
Bingham University Teaching Hospital, and Plateau State 
Specialist Hospital while written informed consent was 
obtained from parents/caregivers of the participating 
neonates
Results
A total of 150 icteric neonates (92 males and 58 females) 
were studied. Mean age at presentation was 3.28 ± 3.11 
days with 78 (84.4%) of the males and 55 (94.8%) of the 
females in the 0-5 days age group (Table 1).
Table 1: Age at presentation and sex distribution of study subjects 
Age (days)    Sex   Total 
  Male   Female
n (%)      
 
n (%)  
0-5  78 (84.4)    55 (94.8)      133  
6-10  11 (12.0)      2 (3.4)  13 
11-15    1 (1.1)    0 (0.0)  
    
1 
16-20    2 (2.2)    0 (0.0)  
    
2 
21-25    0 (0.0)    1 (1.7)  
    
1  
26-28    0 (0.0)  
   
0 (0.0)        0
 Total  92 (100)     58 (100)  150 
Parenthesis ≡ Percentage total
Age at detection of jaundice
The mean age at detection of jaundice amongst the icteric 
neonates recruited for this study was 2.86 ± 1.67, a median 
of 2.00 days within a range of 1-12 days (Table 2).
Icterogenic agents used
Icterogenic agent use was identified in 70 (46.7%) of the 
study subjects with naphthalene balls in 19 (12.7%), 
menthol powder 8 (5.3%), traditional herbs 6 (4.0%), 
Mentholatum 5 (3.3%), and Aboniki in 3 (2.0%). 
Combinations of two or more were used on 29 (19.3%) of 
these neonates while there were no identifiable icterogenic 
agents used on 80 (53.3%) of these subjects (Table 2).
Haematological parameters, total serum bilirubin and 
G6PD activity of all subjects
The haemoglobin concentration of the study subjects was 
in a range of 11.33-22.30 g/dL with a mean of 15.90 ± 2.23 
g/dL, and a median of 15.69 g/dL while the mean 
haematocrit was in a range of 0.34-0.67 with a mean of 0.47 
± 0.06 and median of 0.45. The study subjects had 
reticulocyte count in the range of 0.50-3.90 %, mean count 
of 2.42 ± 0.71% and a median of 2.50 %. 
The total leucocyte count was in the range of 2.00-16.00 (x 
9 910 /L) with a mean of 7.10 ± 2.76 and median of 6.75 x 10 /L 
9while the platelet count (x 10 /L) was in the range of 80.00-
446.00 with a mean of 228.45 ± 85.57 and median of 200.00.
The mean serum bilirubin of the 150 study subjects was 
found to be 205.01 ± 96.57µmol/L with a mode of 
184.50µmol/L and a range of 86.70-606.00µmol/L.
Eighty-nine (59.3%) of the icteric neonates were G6PD 
normal with a mean G6PD activity level of 
10.92±4.24IU/gHb while 61 (40.7%) were G6PD deficient 
with a mean G6PD activity level of 3.79±1.37 IU/gHb 
(Table 2).
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µmol/L. Twelve (13.5%) of the G6PD normal neonates 
exposed to naphthalene balls had a mean total serum 
bilirubin of 213.0 ± 78.1 µmol/L while 5 (5.6%) of the G6PD 
normal neonates were exposed to traditional herbs and 
had a mean total serum bilirubin of 239.1 ± 107.3 µmol/L. 
Thirty-seven (60.7%) of the G6PD deficient neonates in this 
study were not exposed to any icterogenic agent. The use of 
icterogenic agents in relation to G6PD status and degree of 
hyperbilirubinaemia showed no statistically significant 
difference with P-values > 0.05 while a Spearman's rank 
correlation coefficient (r ) between the icterogenic agents s
and degree of hyperbilirubinaemia was 0.99 depicting a 
strong positive correlation.
Table 2: Relevant clinical data and Laboratory parameters of study subjects 
Parameters    n; 150  
Age jaundice was noticed (days; mean + SD)      2.86 ± 1.67 
Icterogenic agent use; n (%)        70 (46.7) 
Haemoglobin concentration (g/dL; mean ± SD)  15.90 ± 2.23
Haematocrit (mean ± SD)        0.47 ± 0.06 
Retics (%; mean ± SD)        2.40 ± 0.73  
Leucocyte count (x109/L; mean ± SD)        7.10 ± 2.76 
Platelet (x109/L; mean ± SD)        228.45 ± 85.57 
Serum bilirubin (µmol/L; mean ± SD)        205.01 ± 96.57 
G6PD activity level (n) (IU/gHb; mean + SD)      
  G6PD Normal     (89) 10.92±4.24  
  G6PD Deficient  (61) 3.79±1.37 
G6PD status, exposure to Icterogenic agents and severity 
of hyperbilirubinaemia
Seventy (46.7%) of the mothers whose babies were enrolled 
in this study use certain agents for baby care and as 
medication during or after delivery. There was no 
identifiable risk factor in 80 (53.3%) of the neonates.
Table 3 shows the frequency of the different agents the 
neonates were exposed to in relation to G6PD activity level 
and degree of hyperbilirubinaemia. Seven (11.5%) of the 
G6PD deficient neonates were exposed to naphthalene 
balls and had mean total serum bilirubin of 168.1 ± 48.5 
µmol/L while 1 (1.1%) of them had exposure to traditional 
herbs with mean total serum bilirubin of 518.6 ± 0.00 
Table 3: G6PD status, exposure to icterogenic agents and hyperbilirubinaemia
Icterogenic agent        G6PD Deficient         G6PD Normal  
 Exposure    n (%)       SB (µmol/L)    n (%)    SB (µmol/L)       t      p value    Total
Abk    2 (3.3)       166.3 ± 88.5       1 (1.1)    188.6 ± 00.0     0.21   0.75  3
MP     3 (4.9)       137.4 ± 53.5       5 (5.6)    186.3 ± 36.9 1.55   0.17  8
Mt    3 (4.9)       346.6 ±193.2      2 (2.3)    149.5 ± 19.0     1.37   0.27  5
Np    7 (11.5)      168.1 ± 48.5       12 (13.5)      213.0 ± 78.1     1.37   0.18  19
TH    1 (1.6)    518.6 ± 00.0       5 (5.6)    239.1 ± 107.3   2.38   0.08  6
MP + Mt       - - 1 (1.1)    120.8 ± 00.0        - - 1
Np + MP    3 (4.9)    296.7 ± 152.6      6 (6.7)    172.8 ± 57.6     1.85   0.11  9
Np + Mt     2 (3.3)    227.1 ± 171.7      2 (2.3)    110.4 ± 33.5     0.94   0.45  4
Rb + Mt         - - 1 (1.1)     200.2 ± 00.0    - - 1
TH + MP         -
                
-
 
3 (3.4)     171.3 ± 97.9    -
  
- 3
TH + Np         - - 1 (1.1)    326.2 ± 00.0    - - 1
TH + MP + Abk     -
  
-
        
1 (1.1)    184.0 ± 00.0    -
    
- 1
Np + MP + Abk    - - 2 (2.3)    152.0 ± 29.8    - - 2
Np + MP + Mt      1 (1.6)       141.1 ± 00.0    2 (2.3)    171.5 ± 8.8    - - 3
Np + MP + TH     1 (1.6)    154.7 ± 0.00    1 (1.1)    185.0 ± 0.00   - - 2
Np + Mt + TH      1 (1.6)    203.0 ± 00.0    - - - - 1
Np+MP+Mt+TH      - - 1 (1.1)    606.0 ± 00.0         - - 1  
Not exposed    37 (60.7)  223.5 ± 103.0    43 (48.3)    185.1 ± 67.5       2.00   0.05  80
Total    61 (100)    89 (100)  150
Abk-Aboniki, MP-Menthol Powder, Mt-Mentholatum, Np-Naphthalene balls, TH-Traditional Herbs, Rb-Robb
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Discussion
Frequency of exposure to icterogenic agents in the G6PD 
deficient neonates was not too different when compared to 
the G6PD normal neonates as obtained from history. The 
study showed that both the G6PD deficient and G6PD 
normal neonates had similar exposure to icterogenic 
agents with no remarkable difference in the severity of 
hyperbilirubinaemia, but a strong positive correlation was 
established between the use of icterogenic agent and 
severity of hyperbilirubinaemia (r  0.99). This report is in s
contrast to studies from other countries who had 
documented that hyperbilirubinaemia were significantly 
higher among G6PD deficient neonates exposed to certain 
icterogenic agents compared to G6PD normal neonates 
17- 20who had also been exposed.  However, same studies 
have agreed with the fact that hyperbilirubinaemia often 
occurs with no apparent offending factor or known 
17- triggers of haemolysis giving such agents a doubtful role. 
20 They further stated that G6PD deficiency could act as an 
independent icterogenic factor increasing the risk of 
developing significant hyperbilirubinaemia in the absence 
20of other causes.  In contrast to the finding in this study, 
Owaet al. and Sodeindeet al. in studies conducted in 
Nigeria declared a direct association between exposure to 
icterogenic agents and severe hyperbilirubinaemia with its 
21, 22attendant consequences.  Furthermore, other previous 
investigations have documented an association between 
exposure to certain icterogenic agents, haemolysis and 
G6PD deficiency, but not all of the G6PD deficient 
23individuals exhibited haemolysis.  This finding may be 
attributed to the fact that G6PD variants play a significant 
role  in  the development of  haemolysis  and 
hyperbilirubinaemia even in the presence of an icterogenic 
 23agent.  Haemolysis is known to be common in persons 
with G6PD Class II variant and rarely does it occur in 
+individuals with the G6PD A  variant even after exposure 
to chemicals like naphthalene and menthol or drugs like 
23primaquine.  However, the limitation of this study and 
those with the contrasting views is that no genetic testing 
aimed at identifying the predominant G6PD variants was 
done. Genetic testing is therefore important as it will assist 
in characterizing the G6PD variants in each population 
group and help in determining the clinical course of the 
disorder with the view of instituting appropriate 
management strategy early. 
Conclusion
The frequency of exposure to the icterogenic agent was 
generally high in the deficient and normal neonates 
exposing the level of ignorance about the dangers of such 
agents in this environment. It is also worthy of note that 
neonates exposed to traditional herbs alone or in addition 
to other icterogenic agents had higher serum bilirubin 
concentration. There is, therefore, the need for public 
health education on the dangerous effect of these 
icterogenic agents with women of childbearing age and 
pregnant mothers being the target population. A further 
study on G6PD variants and the effect of the different 
icterogenic agents' especially traditional herbs available in 
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